Speech-Language Pathologists in Washington - Medicare Status, Address, Contact

3870 Speech-Language Pathologists found. Showing 1 - 20

Morgan Rhea Hebish, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1801 Bay Ave, Aberdeen, WA 98520 Phone: 360-538-8805

Patricia Lynne Warnick, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 915 Anderson Dr, Aberdeen, WA 98520 Phone: 360-532-8330

Chelsea Wirt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 915 Anderson Dr, Aberdeen, WA 98520 Phone: 360-532-8330

Dr. Alicia Henderson, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1254 N L St, Aberdeen, WA 98520 Phone: 605-382-0023

Margaret Blake, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1006 N H St, Aberdeen, WA 98520 Phone: 603-731-9430

Mrs. Judith Ann Mcculloch, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1006 North H St, Speech Therapy, Aberdeen, WA 98520 Phone: 360-537-6032    Fax: 360-537-6026

Roberta Player Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 216 N G St, Aberdeen, WA 98520 Phone: 360-538-2023

Ms. Geri C Wright, MS/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1006 North H Street, Aberdeen, WA 98520 Phone: 360-537-6032    Fax: 360-537-6026

Miss Stephanie Marie Sladek, M.S., CF/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1006 N H St, Aberdeen, WA 98520 Phone: 360-537-6032

Mr. Michael Dean Baran, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Harbor Regional Hospital, 915 Anderson Drive, Aberdeen, WA 98520 Phone: 360-532-8330

Mrs. Gina Suzanne Rogers, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1006 N H St, Aberdeen, WA 98520 Phone: 360-537-6032

Trisha Griggs Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 216 N G St, Aberdeen, WA 98520 Phone: 360-538-2083

Melissa Karen Barnes, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1006 N H St, Aberdeen, WA 98520 Phone: 360-537-6032    Fax: 360-537-6026

Carol Marie Krueger, B.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 216 N G St, Aberdeen, WA 98520 Phone: 360-538-2018

Elena Gutierrez Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1006 N H St, Aberdeen, WA 98520 Phone: 360-537-6032

Marissa Josianne James Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 915 Anderson Dr, Aberdeen, WA 98520 Phone: 360-532-8330

James Almon Mitchell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 920 Anderson Dr, Aberdeen, WA 98520 Phone: 360-532-5122

Ms. Crystal Rae Ahlborg, MS, CFY/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1006 N H St, Aberdeen, WA 98520 Phone: 360-533-8500

Mrs. Heidi Iwashita, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 920 Anderson Dr, Aberdeen, WA 98520 Phone: 360-532-5122    Fax: 360-532-9048

Mrs. Nichole Doreen Wilder, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2700 Simpson Ave Ste 201, Aberdeen, WA 98520 Phone: 360-537-2743    Fax: 360-537-6812

News Archive

Gilenya - pill for relapsing-remitting multiple sclerosis recommended by NICE

The National Institute for Health and Clinical Excellence (Nice) issued new draft guidance recommending fingolimod (brand name Gilenya) on the NHS for some patients with a form of MS. The new drug can help reduce the number of relapses in adults with highly active relapsing-remitting multiple sclerosis (RRMS), which is characterized by periods when symptoms worsen and then improve.

Disruption of brain signals contributes to increased pain sensitivity in fibromyalgia patients

New research indicates that a disruption of brain signals for reward and punishment contributes to increased pain sensitivity, known as hyperalgesia, in fibromyalgia patients. Results published in Arthritis & Rheumatism, a journal of the American College of Rheumatology, suggest that this altered brain processing might contribute to widespread pain and lack of response to opioid therapy in patients with fibromyalgia.

ARIAD Pharmaceuticals' Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment

ARIAD Pharmaceuticals, Inc. today announced that the European Commission has granted a marketing authorization for Iclusig (ponatinib) as an orphan medicinal product for two indications.

IMRT safe and effective treatment for paranasal tumors: Study

Treating paranasal sinus cancer with three-dimensional radiation that conforms to the shape of the tumor-a technique that minimizes side effects such as severe dry mouth and vision problems-is safe and effective, research at Fox Chase Cancer Center shows. Aruna Turaka, M.D., radiation oncologist at Fox Chase, will present the results on November 2nd at the annual meeting of the American Society for Radiation Oncology.

Synexus completes CT327 phase II psoriasis trial for Creabilis

Synexus has completed a phase II study for the European biotech, Creabilis, recruiting 26 patients in the UK to the psoriasis trial of its CT327 lead product in just 2 weeks, as part of an international proof-of-concept study. The company delivered the targeted number of patients well within the agreed timelines and budget.

Read more Medical News

› Verified 5 days ago

• 1(current)
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »